Far-Red Fluorescent Senescence-Associated β-Galactosidase Probe for Identification and Enrichment of Senescent Tumor Cells by Flow Cytometry

Overview

This article presents a protocol for the quantification of senescent cancer cells using flow cytometry, focusing on cells induced by chemotherapy. The method allows for rapid detection and analysis of therapy-induced senescence in tumor cells.

Key Study Components

Area of Science

• Cancer Biology
• Cell Biology
• Flow Cytometry

Background

• Senescence in tumor cells is a critical area of research in cancer therapy.
• Traditional microscopy-based assays are slower and less reliable.
• Flow cytometry offers a more efficient alternative for detecting senescent cells.
• Using multiple markers enhances the accuracy of senescence identification.

Purpose of Study

• To develop a rapid flow cytometry assay for detecting senescent cancer cells.
• To improve the reliability of senescence detection through dual marker usage.
• To enable the enrichment of senescent cells for further analysis.

Methods Used

• Multi-parameter flow cytometry for cell quantification.
• Co-staining with fluorescent antibodies for additional target detection.
• Flow cytometric sorting to enrich viable senescent cells.
• Application in cultured cancer cell lines and murine tumor samples.

Main Results

• The flow cytometry assay is faster than existing microscopy methods.
• Utilization of two markers improves the reliability of senescent cell identification.
• Successful detection of senescent cells in both cell culture and tumor samples.
• Enrichment of senescent cells facilitates downstream analysis.

Conclusions

• The developed protocol enhances the detection of therapy-induced senescence.
• Flow cytometry is a valuable tool for cancer research.
• This method can contribute to understanding cancer biology and therapy.

Frequently Asked Questions